Abstract
MDS-345 Nature of Clinical Response and Depth of Molecular Response in Patients With TP53-Mutant Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Treated With Magrolimab With Azacitidine
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have